Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 00:39:03 - browse：3285

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Elizabeth Holmes on track for early release from her 11

WSS

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Experts study whether long Covid risk adds up with each reinfection

Thermo Fisher plant for manufacturing gene therapies to expand

Charles Manson follower Leslie Van Houten released from prison after 53 years

Biotech lab space demand falls sharply

California’s proposed $25 per hour health care minimum wage

Wikipedia

Wikipedia

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Emergency workers more likely to restrain Black patients: study

How one medical school became remarkably diverse

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

As demand for Covid shots wanes, Moderna seeks its next success

Why 40% Americans with Parkinson’s don’t see a neurologist

In age of alternative facts, a scholarly course on calling out crap

Living with Fabry disease, a condition that causes chronic pain

Medicare details structure of new drug price negotiation program

Senate HELP committee spars over health care workforce policies

leisure time

What Congress can do to address the rural doctor shortage

Why ADHD is under

Drug for rare kidney disease narrowly misses mark in clinical trial

Living with Fabry disease, a condition that causes chronic pain

Why 40% Americans with Parkinson’s don’t see a neurologist

CDC's new outbreak response network to include Northeastern

leisure time

Wikipedia

knowledge

entertainment